Trump administration officials met with medical device lobbyists earlier this month to discuss a draft rule dubbed “ExCITe” that would expedite coverage of innovative technology, and briefing materials from the meeting include an industry proposal that CMS provisionally cover certain medical devices and diagnostics following FDA approval while the manufacturer continues to collect additional data on the technology. Advanced Medical Technology Association Executive Vice President for Payment and Health Care Delivery Policy Don May said the group isn't entirely sure...